News & Insights

Emergent Bioservices News, Insights & Events

Stay informed with news, insightful thought leadership, featured articles and engaging content from Emergent Bioservices and check out what events we’ll be attending throughout the year.

03.12.2021

Genetic Vaccine Platforms Demonstrate Their Potential

In a recent Pharmaceutical Technology article, Emergent experts provide their insights on selection of technologies for vaccine...

02.13.2021

Emergent Enters Into a New CDMO Agreement with Providence Therapeutics to Provide Fill/Finish Drug Product Manufacturing

Emergent has entered into a new CDMO agreement with Providence Therapeutics to provide fill/finish drug product manufacturing...

01.25.2021

Humanigen and Emergent BioSolutions Announce Contract Development and Manufacturing Agreement for Phase 3 COVID-19 Therapeutic Candidate Lenzilumab™

GAITHERSBURG, MD. and BURLINGAME, CA. – Jan. 25, 2021—Emergent BioSolutions Inc.(NYSE:EBS) (Emergent) andHumanigen, Inc....

12.01.2020

BioPharm Intl Regulatory Sourcebook: GMPs Guide COVID-19 Vaccine Manufacturing

Excerpt taken from BioPharm International October 2020 Regulatory Sourcebook article titled: GMPs Guide COVID-19 Vaccine...

11.30.2020

Factoring Stability in the Biologic Drug Mix

Jee Look, senior director of drug product development for Emergent BioSolutions recently contributed to an article in ...

10.31.2020

Gene therapy solution: The value of a CDMO as your end-to-end partner

With ongoing advances in science and technology, the cell and gene therapy pipeline has grown especially robust over the past...